Decreased interleukin-10 production by neonatal monocytes and T cells: Relationship to decreased production and expression of tumor necrosis factor- α and its receptors

Pediatric Research

Volumn 40, Issue 3, 1996, Pages 475-483

  Chheda, Sadhana ^a   Palkowetz, Kimberly H ^a   Garofalo, Roberto ^a   Rassin, David K ^a   Goldman, Armond S ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 10; MONOCLONAL ANTIBODY CD3; PHORBOL 13 ACETATE 12 MYRISTATE; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; LYMPHOCYTE ACTIVATION; MONOCYTE; NEWBORN; PRIORITY JOURNAL; T LYMPHOCYTE; UMBILICAL CORD BLOOD;

EID: 0029788168     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199609000-00018     Document Type: Article

References (61)

1. Hill HR 1987 Biochemical, structural, and functional abnormalities of polymorphonuclear leukocytes in the neonate. Pediatr Res 22:375-382
2. Wilson CB, Lewis DB, Penix LA 1996 The physiologic immunodeficiency of immaturity. In: Stiehm ER (ed) Immunologic Disorders in Infants and Children. WB Saunders, Philadelphia, pp 253-295
3. Marodi L, Kaposzata R, Campbell DE, Polin RA, Csongor J, Johnston Jr RB 1994 Candidacidal mechanisms in the human neonate: impaired IFN-γ activation of macrophages in newborn infants. J Immunol 153:5643-5649
4. Adderson EE, Johnston JM, Shackerford PG, Carroll WL 1992 Development of the human antibody repertoire. Pediatr Res 32:257-263
5. Peltola H, Kayhty H, Virtanen M, Makela PH 1984 Prevention of Haemuphilus influenzae type b bacterial infections with the capsular polyaccharide vaccine. N Engl J Med 310:1561-1565
6. Burgio GR, Hanson LÅ, Ugazio AG (eds) 1987 Immunology of the Neonate. Springer, Vienna
7. Rognum TO, Thrane PS, Stoltenberg L, Vege Å, Brandstzaeg P 1992 Development of intestinal mucosal immunity in fetal life and the first postnatal months. Pediatr Res 32:145-149
8. Hayward AR, Groothius J 1991 Development of T cells with memory phenotype in infancy. Adv Exp Biol Med 310:71-76
9. Maccario R, Chirico G, Mingrat G, Arico M, Lanfranchi A, Montagna D, Moretta A Rondini G 1993 Expression of CD45R0 antigen on the surface of resting and activated neonatal T lymphocyte subsets. Biol Neonate 64:346-353
10. low T cells in human cord blood. J Immunol 152:5613-5623
11. low T cells in newborn blood. Biol Neonate 69:128-132
12. English BK, Burchett SK, English JD, Amman A, Wara DW, Wilson CB 1988 Production of lymphotoxin and tumor necrosis factor by human neonatal mononuclear cells. Pediatr Res 24:717-722
13. Cairo MS, Suen Y, Knoppel E, van de Yen C, Nguyen A, Sender L 1991 Decreased stimulated GM-CSF expression and GM-CSF gene expression but normal numbers of GM-CSF receptors in human term newborns as compared with adults. Pediatr Res 30:362-367
14. Cairo MS, Suen Y, Knoppel E, Dana R, Park L, van de Yen C, Sender L 1992 Decreased G-CSF and IL-3 production and gene expression from mononuclear cells of newborn infants. Pediatr Res 31:574-578
15. Lewis DB, Yu CC, Meyer J, English BK, Kahn SJ, Wilson CB 1991 Cellular and molecular mechanisms for reduced interleukin 4 and interferon-γ production by neonatal T cells. J Clin Invest 87:194-202
16. Wilson CB, Westfall J, Johnson L, Lewis DB, Dower SK, Alpen AR 1986 Decreased production of interferon-γ by human neonatal cells: intrinsic and regulatory deficiencies. J Clin Invest 77:860-867
17. Yachie A, Takano N, Yokwi T, Kato K, Kasahara Y, Miyawaki T, Taniguchi N 1990 The capabilities of neonatal leukocytes to produce interleukin-6 on stimulation. Assessed by whole blood culture. Pediatr Res 27:227-223
18. Yachie A, Takano N, Ohta K, Uehara T, Fujita S, Miyawaki T, Taniguchi N 1992 Defective production of interleukin-6 in very small premature infants in response to bacterial pathogens. Infect Immun 60:749-753
19. Schibler KR, Liechty KW, White WL, Rothstein G, Christensen RD 1992 Defective production of interleukin-6 by monocytes: a possible mechanism underlying several host defense deficiencies of neonates. Pediatr Res 31:18-21
20. Weatherstone KB, Rich EA 1989 Tumor necrosis factor/cachectin and interleukin-1 secretion by cord blood monocytes from premature and term neonates. Pediatr Res 25:342-346
21. de Bont ESJM, Martens A, van Raan J, Samson G, Fetter WPF, Okken A, de Leij HFM 1993 Tumor necrosis factor-α, interleukin-1β, and interleukin-6 plasma levels in neonatal sepsis. Pediatr Res 33:380-383
22. Aerde JEE 1991 Acute respiratory failure and bronchopulmonary dysplasia. In: Hay WW (ed) Neonatal Nutrition and Metabolism. Mosby Year Book, St. Louis, pp 467-506
23. Kliegman RM, Walker WA, Yolken RH 1993 Necrotizing enterocolitis: research agenda for a disease of unknown etiology and pathogenesis. Pediatr Res 34:701-708
24. Sharma R, Prem RR, Salisbury S 1994 Interleukin-1β, interleukin-2, and tumor necrosis factor-α levels in infants with necrotizing enterocolitis (NEC). Pediatr Res 35:225A(abstr)
25. Gaylord M, Smith Z, Lorch V, Blank M, Snyder F 1994 Elevated platelet activating factor levels in the first week of life are associated with the severity of bronchopulmonary dysplasia in very low birthweight infants. Pediatr Res 35:333A(abstr)
26. Nijinimbam CG, Cole CH, Frantz III ID 1994 Interleukin-1 receptor antagonist (IL-1ra) and interleukin-8 (IL-8) levels in tracheal aspirates of infants with respiratory distress syndrome (RDS) and bronchopulmonary dysplasia (BPD). Pediatr Res 35:347A(abstr)
27. Vieira P, de Waal Malefyt R, Dang M, Johnson KE, Kastelein R, Moore KW 1991 Isolation and expression of human cytokine synthesis inhibitory factor (CSIF/IL-10) cDNA clones: homology to Epstein-Barr virus open reading frame BCRF1. Proc Natl Acad Sci USA 88:1172-1176
28. de Waal Malefijt R, Yssel RH, Ronocarlo H, Spits H, de Vries JE 1992 Interleukin 10. Curr Opin Immunol 4:314-320
29. Howard M, O'Garra H, Ishida R, de Waal Malefyt R, de Vries JE 1992 Biological properties of IL-10. J Clin Immunol 4:239-247
30. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A 1991 IL-10 inhibits cytokine production by activated macrophages. J Immunol 147:3815-3822
31. Fiorentino DF, Zlotnik A, Viera P, Mosmann TR, Howard M, Moore KW, O'Garra A 1991 IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 146:3444-3451
32. de Waal Malefijt R, Abrams J, Bennett B, Figdor CG, de Vries JE 1991 Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209-1220
33. Wu-J AU, Cunha FQ, Liew FY, Weiser WY 1993 IL-10 inhibits the synthesis of migration inhibitory factor and migration inhibitory factor-mediated macrophage activation. J Immunol 151:4325-4332
34. Cassatella MA, Meda L, Bonora S, Ceska M, Constantin G 1993 Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes: evidence for an autocrine role of tumor necrosis factor and IL-1β in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 178:2207-2211
35. D Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G 1993 Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 178:1041-1048
36. + T cell clones and resting T cells: specific inhibition of IL-2 production and proliferation. J Immunol 150:4754-4765
37. Briere F, Bridon JM, Servet C, Roussel F, Zurawski G, Banchereau J 1993 IL-10 and IL-13 as B cell growth and differentiation factors. Nouv Rev Fr Hematol 35:233-235
38. Armitage RJ, Macduff BM, Spriggs MK, Fanslow WC 1993 Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J Immunol 150:3671-3680
39. Rousset F, Garcia E, Defrance T, Peronne C, Vezzio N, Hsu DH, Kastelein R, Moore KW, Banchereau J 1992 Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 89:1890-1893
40. Defrance T, Vanbervliet B, Briere F, Durand I, Rousset F, Banchereau J 1992 Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J Exp Med 175:671-682
41. Howard M, Muchamuel T, Andrrade S, Menon S 1993 Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 177:1205-1208
42. Marchant A, Deviere J, By1 B, De Groote D, Vincent J-L, Goldman M 1994 Interleukin-10 production during septicaemia. Lancet 343:707-708
43. Kühn R, Löher J, Rennick D, Rajewsky K, Müller W 1993 Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263-274
44. Garofalo R, Chheda S, Mei F, Palkowetz KH, Rudloff HE, Schmalstieg FC, Rassin DK, Goldman AS 1995 Interleukin-10 in human milk. Pediatr Res 37:444-449
45. Goldman AS 1993 The immune system of human milk: antimicrobial, antiinflammatory, and immunomodulating properties. Pediatr Infect Dis J 12:664-672
46. Brooks EG, Schmalstieg FC, Wirt DP, Rosenblatt HM, Adkins LT, Lookingbill DP, Rudloff HE, Rakusan TA, Goldman AS 1990 A novel X-linked combined immunodeficiency disease. J Clin Invest 86:1623-1631
47. Wanidworanun C, Strober W 1993 Predominant role of tumor necrosis factor-α in human monocyte IL-10 synthesis. J Immunol 151:6853-6861
48. Brockhaus M, Schoenfeld H-J, Schlaeger E-J, Hunziker W, Lesslauer W, Loetscher H 1990 Identification of two types of tumour necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 87:3127-3131
49. Burchett SK, Weaver WM, Westall JA, Laren A, Kronheim S, Wilson CB 1988 Regulation of tumour necrosis factor/cachectin and interleukin-1 secretion in human mononuclear phagocytes. J Immunol 140:3473-3481
50. + T cell clones and peripheral blood T cells. J Immunol 149:2378-2384
51. Lee SM, Knoppel E, van de Ven C, Cairo MS 1993 Transcriptional rates of granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, interleukin-3, and macrophage colony-stimulating factor genes in activated cord versus adult mononuclear cells: alteration in cytokine expression may be secondary to posttranscriptional instability. Pediatr Res 34:560-564
52. Zola H, Fusco M, Macardle PJ, Fliego L, Roberton D 1995 Expression of cytokine receptors by human cord blood lymphocytes: comparison with adult blood lymphocytes. Pediatr Res 38:397-403
53. Agostini C, Zambello R, Cerutti A, Enthammer C, Facco M, Milani A, Sancetta R, Garbisa S, Semenzato G 1995 Expression of TNF receptors by T cells and membrane TNF-α by alveolar macrophages suggests a role for TNF-α in the regulation of the local immune responses in the lungs of HIV-1-infected patients. J Immunol 154:2928-2938
54. Leeuwenberg JFM, Dentener MA, Buurman WA 1994 Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes. J Immunol 152:5070-5076
55. Porteu F, Nathan C 1990 Shedding of tumour necrosis factor receptors by activated human neutrophils. J Exp Med 172:599-607
56. Austgulen R, Liabakk N-B, Lein E, Espevik T 1993 Increased levels of soluble tumour necrosis factor-α receptors in serum from pregnant women and in serum and urine samples from newborns. Pediatr Res 33:82-86
57. Austgulen R, Johnsen H, Kjollesdal AM, Liabakk N-B, Espevik T 1993 Soluble receptors for tumour necrosis factor: occurrence in association with normal delivery at term. Obstet Gynecol 82:343-347
58. Tartaglia L, Goeddel D 1992 Two TNF receptors. Immunol Today 13:151-153
59. Chomarat P, Rissoan M-C, Banchereau J, Miossec P 1993 Interferon γ inhibits interleukin 10 production by monocytes. J Exp Med 177:523-527
60. Lucas A, Cole TJ 1990 Breast milk and neonatal necrotising enterocolitis. Lancet 336:1519-1525
61. Jones CA, Cavabvab R, Kwong YC, Stotts CL, de Lemos RA Decreased IL-10 expression in the lungs of preterm infants with hyaline membrane disease 1995. Pediatr Res 37:2002A(abstr)